Neurotensin in Small Cell Lung Carcinoma
Author Information
Author(s): M. Goedert, J.G. Reeve, P.C. Emson, N.M. Bleehen
Primary Institution: MRC Neurochemical Pharmacology Unit and MRC Clinical Oncology and Radiotherapeutics Unit, Medical Research Council Centre, Medical School, Cambridge, UK
Hypothesis
It is unknown whether the tumour hormone production is a simple reflection of derepression of genetic material or whether the hormones exert a positive influence on the growth of the tumour cells.
Conclusion
High levels of neurotensin-like immunoreactivity were found in human small cell lung carcinoma lines, while no immunoreactivity was present in non-small cell carcinoma lines.
Supporting Evidence
- High levels of neurotensin-like immunoreactivity were found in all small cell lung carcinoma lines examined.
- No neurotensin-like immunoreactivity was detected in non-small cell lung carcinoma lines.
- Neurotensin-like immunoreactivity was not detectable in post-mortem human lung tissue.
Takeaway
Researchers found a lot of a substance called neurotensin in certain lung cancer cells, but not in other types of lung cancer or normal lung tissue.
Methodology
The study involved extracting and analyzing tissue samples from small cell lung carcinoma cell lines and post-mortem human lung tissue using various biochemical techniques.
Limitations
The study did not determine the presence of neurotensin receptors in the small cell carcinoma lines.
Participant Demographics
The study involved small cell lung cancer lines derived from human tissues and post-mortem lung tissue from elderly patients.
Want to read the original?
Access the complete publication on the publisher's website